Japan to work with India in finding sickle cell anaemia remedy

August 31, 2014 02:53 pm | Updated 03:39 pm IST - Kyoto

Prime Minister Narendra Modi and iPS cell researcher and Nobel Prize laureate, Shinya Yamanaka, chat during Modi's visit at Kyoto Universaity in Kyoto.

Prime Minister Narendra Modi and iPS cell researcher and Nobel Prize laureate, Shinya Yamanaka, chat during Modi's visit at Kyoto Universaity in Kyoto.

Japan on Sunday agreed to work with India in developing a treatment for the sickle cell anaemia after Prime Minister Narendra Modi sought help for finding remedy to the deadly disease commonly found among tribals in India.

Modi, who has been keenly looking for a remedy to the disease since his days as Chief Minister of Gujarat, discussed the issue with Nobel Prize winner for Medicine (2012) S Yamanaka when he visited the Kyoto University.

Yamanaka is also the Director of the University. The Prime Minister, on the second day of his tour, raised the issue during his visit to the Stem Cell Research facility and discussed whether Japan could be of help in this regard.

“I wanted to understand stem cell research because cultural heritage matters as much to me as scientific heritage. I want to integrate both to make India a developed country. It was a good opportunity for me,” Modi said.

The Prime Minister discussed the possibility of cooperation in finding a treatment for the disease, said External Affairs Ministry spokesman Syed Akbaruddin.

Sources said the Japanese side said it would work with India in jointly finding the treatment.

The sources said Modi, since his days as Gujarat Chief Minister, has been trying to see if any solution could be found to the disease but has been helpless as no cure has been invented yet.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.